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Available online 30 July 2011Abstract Hematopoietic Stem Cells (HSCs) are responsible for the production and replenishment of all blood cell types during
the entire life of an organism. Generated during embryonic development, HSCs transit through different anatomical niches
where they will expand before colonizing in the bone marrow, where they will reside during adult life. Although the existence of
HSCs has been known for more than fifty years and despite extensive research performed in different animal models, there is
still uncertainty with respect to the precise origins of HSCs. We review the current knowledge on embryonic hematopoiesis and
highlight the remaining questions regarding the anatomical and cellular identities of HSC precursors.
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doi:10.1016/j.scr.2011.07.002The concept of hematopoietic stem cells: More
than a century ago
The development of cell biology research coincides with the
advance of microscopes in the 19th century. It was finally
possible to directly observe the various blood cell types and to.
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1999).On the basis of his observations, theGermanpathologist
Franz Ernst Christian Neumann (1834–1918) concluded that
the site of blood formation was the bone marrow. He also
proposed the pioneer theory in which one cell might be at the
origin of all blood cell lineages. The Russian scientist Alexander
A. Maximow (1874–1928) also developed and introduced the
theory of a common cell for the complete blood-building
system or hematopoiesis, as well as the idea of a micro-
environmental niche for these cells within the bone marrow
(Maximow, 1909). The concept of Hematopoietic Stem Cells
(HSCs), although very controversial at the time, was born and
has led to the beginning of stem cell research (Ramalho-Santos
and Willenbring, 2007).
Ernest A. McCulloch and James E. Till gave the first
experimental proof of the stem cell theory by performing
the transplantation of bone marrow cells into irradiated mice
(Till and McCulloch, 1961; Becker et al., 1963). These cells
gave rise to myeloid multilineage colonies in the spleen of
transplanted animals, the number of colonies being propor-
tional to the number of injected cells. Such experiments
demonstrated the multilineage potential of single bone
marrow cells (so-called CFU-S, Colony-Forming Unit in the
Spleen) (Siminovitch et al., 1963). However, because these
cells only have limited self-renewing capabilities, they are not
considered to be true stem cells which must be both
multipotent and self-renewing. E. Donnall Thomas performed
the first successful stem cell transplantation on identical
human twins in 1957 (Thomas et al., 1957). This has formally
demonstrated that intravenous injection of bone marrow cells
allows long-term repopulation with the production of new
blood cells. The oncologist Georges Mathé also performed
transplantations on Yugoslavian nuclear workers whose bone
marrows were damaged by irradiation (Mathé et al., 1959).
Later on, he successfully cured a patient with leukemia (pre-
treated by irradiation) after allogenic bone marrow transplan-
tation (Mathé et al., 1963). For nearly 50 years, such trans-
plantations have been performed to treat patients with blood-
related disorders. Adult HSCs can now be highly enriched with
a combination of several surfacemarkers. However, no unique
HSC marker has so far been identified, as is the case for most
stem cell categories. Thus, a functional test is required to
prove that genuine HSCs are present in a cell population. In
vivo transplantation is the gold standard experimental
procedure to prove retrospectively, by analyzing the HSC
progeny, that the cells are capable of multilineage differen-
tiation in addition to self-renewal.
Adult bone marrow, cord blood and mobilized peripheral
blood are sources of HSCs used in transplantation protocols in
the case of many blood-related diseases, such as leukemia.
However, the number of HSCs in these tissues remains low,
which creates a major obstacle for both HSC use in clinical and
fundamental research. Despite extensive studies and a
continuously better understanding of the complicated intrinsic
and extrinsic regulation of HSCs, it is still very difficult to
reproduce in vitro conditions allowing efficient HSC expansion
without inducing cell differentiation (Hofmeister et al., 2007).
Embryonic StemCells (ESC) and induced Pluripotent Stem (iPS)
cells can generate in vitro cells of the different hematopoietic
lineages including erythrocytes, myelocytes and megakaryo-
cytes (Sakamoto et al., 2010). However, the generation of new
HSCs either from ESCs or iPS cells, although very promising,remains very limited to date (Kyba et al., 2002; Burt et al.,
2004). Interestingly, it was recently shown that human
fibroblasts derived from the skin could directly be repro-
grammed to multilineage hematopoietic progenitors after
ectopic expression of the single transcription factor Oct-4
(Szabo et al., 2010). Reprogrammation without the need to
generate artificial pluripotent stem cells might be a promising
direction in the future to generate HSCs in vitro.
Therefore, a major goal remains to understand the
complex cellular and molecular network that controls HSC
generation and expansion. In fact, HSCs that are mainly slow
cycling (Wilson et al., 2008) and reside in the bone marrow
during the entire life of an individual, are not generated
there. They are produced and expanded during embryonic
development before colonizing in the bone marrow prior to
birth (Christensen et al., 2004). Thus, studying HSC
development in the embryo is a powerful tool and a reliable
model to decipher the complex characteristics and regula-
tion of HSCs. We will describe in this review the ontogeny of
the hematopoietic system in different animal models, the
controversies concerning the cellular and anatomical origin
of HSCs and the recent insights into the field, notably
documented by in vivo confocal imaging approaches.
The journey of a hematopoietic stem cell:
From embryo to adult
HSCs areat the foundation of theentire adult blood system.The
multipotency property allows single HSCs to differentiate and
proliferate into more committed progenitors and precursors
that will then produce all mature cells from the erythroid,
myeloid and lymphoid lineages. Given the fast turnover in
mature blood cells, only HSCs, which are by definition able to
self-renew while keeping their multilineage properties, can
sustain blood production during the entire life of an organism.
Embryonic hematopoiesis has been studied in various
animal models (e.g. amphibian, avian, rodent), but the focus
of this chapter will mainly be on the mouse embryonic
model. Adult HSCs are generated during embryonic devel-
opment. The first hematopoietic cells produced in the embryo
are differentiated cells that aremost likely needed at the time
for proper oxygenation and protection of the developing
embryo. The initial site of hematopoietic production is the yolk
sac (YS) (Moore andMetcalf, 1970; Palis et al., 1999; Ferkowicz
and Yoder, 2005). Starting at embryonic day (E)7.25 of mouse
development, this extra-embryonic tissue, composed of both
visceral endoderm and mesoderm, transiently produces large
nucleated erythrocytes termed erythroblasts (Fig. 1A) (Palis
et al., 1999), as well as some macrophages and megakaryo-
cytes (Xu et al., 2001). A layer of endothelial cells will surround
these first blood cells to form specialized structures called
blood islands (Ferkowicz and Yoder, 2005; Haar andAckerman,
1971). Some evidence (reviewed later) led to the idea that
both cell types (hematopoietic and endothelial) are generated
from a common mesodermal precursor known as the heman-
gioblast (Ferkowicz and Yoder, 2005; Shalaby et al., 1995,
1997; Eichmann et al., 1997; Choi et al., 1998; Huber et al.,
2004). Mature cells can easily be identified directly under the
microscope by specific morphological criteria, or by analysis
of surface marker expression using, for example, immuno-
histochemistry. On the other hand, hematopoietic progenitors
Figure 1 First sites of hematopoietic stem/progenitor cell appearance during mouse embryonic development. The scheme
represents the early mouse embryonic development, from E6.0 until E10.5. Different types of hematopoietic cells have been found in
different anatomical sites throughout development. However, it is important to note that the time point of the appearance of
hematopoietic progenitor/stem cells and the site where they are detected differ according to the experimental approach used to
reveal the hematopoietic potential. The hematopoietic potential of the embryonic tissues has been tested directly on freshly isolated
tissues (A) or after an in vitro culture step (B) to reveal a hematopoietic potential undetectable on fresh tissues. The first time points
of appearance of the different hematopoietic stem and progenitor cells are indicated in the different anatomical sites as well as the in
vitro and in vivo assays used to identify the hematopoietic cells. HSC: hematopoietic stem cells, YS: yolk sac, UA: umbilical artery, VA:
vitelline artery, P-Sp: para-aortic splanchnopleura, E: embryonic day post-coitus, WT: wild-type.
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(clonogenic assay). In such a culture system, different types of
lineage-restricted progenitors (erythroid, granulocytic, mac-
rophagic and/or megakaryocytic) can be identified and
quantified for their ability to form colonies by looking at
specific characteristics (e.g. composition, size, color). By
using such assays, it was shown that beginning at E7.5-E8,
erythroid-myeloid progenitors start to appear in the YS (Mooreand Metcalf, 1970; Palis et al., 1999) and in the chorion and
allantois (which later fuse to form the placenta and the
umbilical cord) (Palis et al., 1999; McGrath et al., 2011;
Alvarez-Silva et al., 2003; Corbel et al., 2007; Zeigler et al.,
2006). In addition, it is possible to identify erythroid-myeloid
cells in E6.75 embryos once the cells have been co-cultured on
OP9 stromal cell lines (Furuta et al., 2006) (Fig. 1B). Slightly
later, at E8.5, erythroid–myeloid–lymphoid progenitors are
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region formed by the dorsal aorta, omphalomesenteric (or
vitelline) artery, gut and splanchnopleura) (Godin et al., 1995).
Indeed, B progenitors were identified after co-culture of the
different tissues on S-17 stromal cell line, while T progenitors
were identified in a fetal thymic organ culture assay (Fig. 1A).
Culturing of YS and P-Sp before the establishment of circulation
showed that these multipotent progenitors are of P-Sp origin
(Fig. 1B) (Cumano et al., 1996). At E10, CFU-S are also detected
in the YS and the intra-embryonic Aorta-Gonad-Mesonephros
region (AGM, region corresponding to the earlier P-Sp)
(Medvinsky et al., 1993) (Fig. 1A).
Adult HSCs can be highly purified (Purton and Scadden,
2007; Osawa et al., 1996). This is in contrast to the first HSCs
found in the embryo, which have been more difficult to enrich
thus far (Taoudi et al., 2005). Many markers currently used to
isolate adult HSCs do not apply for embryonic HSCs. Moreover,
surface marker expression on HSCs varies during development
(Robin et al., 2011; McKinney-Freeman et al., 2009) and also
between strain and species. For example, the SLAM marker
CD150, which allows for a high enrichment of HSCs in the adult
bonemarrow (Kiel et al., 2005) and fetal liver (Kim et al., 2006)
when used in combination with the classical marker combina-
tion LSK (Lin−Sca1+ckit+), is not a marker of AGM HSCs
(McKinney-Freeman et al., 2009). The lineage antibody panel
(Lin) has been designed and used routinely to deplete mature
cells from the erythroid, lymphoid and myeloid lineages
(Muller-Sieburg et al., 1986). Such depletion does not apply
to purifying embryonic HSCs because Mac-1 (CD11b), a marker
classically expressed by macrophages/monocytes in adults, is
also expressed by a fraction of AGMHSCs (Sanchez et al., 1996).
Moreover, HSCs and endothelial cells share many surface
markers, reflecting their close developmental relationship
(Garcia-Porrero et al., 1998). The only reliable method used to
identify HSCs is to perform a long-term in vivo assay where the
multilineage repopulation and self-renewal abilities of the cells
are tested after transplantation into primary and secondary
adult wild-type irradiated recipients. Using this standard assay,
HSCs were first detected in the AGM region starting at E10.5
(Fig. 1A) (Medvinsky and Dzierzak, 1996; Muller et al., 1994).
More precisely, HSCs are restricted to the aorta, as shown by
the subdissection of the AGM region to separate the aorta from
the urogenital ridges before performing transplantation (de
Bruijn et al., 2000). HSC activity in the AGM is transient and
stops after E12. Interestingly, HSCs are also found at E10.5 in
two othermajor vessels, the vitelline and umbilical arteries (de
Bruijn et al., 2000) (Fig. 1A). Slightly later (E11–11.5), HSCs are
also detected in othermajor highly vascularized hematopoietic
sites: the YS, placenta and fetal liver (Kumaravelu et al., 2002;
Ottersbach and Dzierzak, 2005; Gekas et al., 2005). Only very
few HSCs (~4–11 cells) are present in the complete mouse
conceptus at E11. By E12, the HSC numbermultiplies by at least
14 times, mainly in the placenta and fetal liver (Kumaravelu et
al., 2002; Gekas et al., 2005). The liver becomes the main HSC
reservoir at mid-gestation until the HSCs start to colonize the
bone marrow at E17 (Christensen et al., 2004). HSCs behave
differently in the embryo (compared to adult) as they transit
through several anatomical sites or niches, and are actively
self-renewing (Morrison et al., 1995; Bowie et al., 2006). The
embryonic microenvironment that composes the successive
niches is still poorly described, but it certainly influences the
equilibrium between HSC self-renewal and differentiation.In comparison, HSC niches in adult bone marrow are well
described (Levesque and Winkler, 2011). Two types of niches,
very close spatially, havebeen reported so far. In theendosteal
niche, HSCs are in close contact to the endosteal bone surface
where the main supportive cell type, the osteoprogenitor
population, maintains HSCs in a quiescent/slow-cycling state
(Calvi et al., 2003; Zhang et al., 2003; Raaijmakers et al., 2010;
Lo Celso et al., 2009). In the second niche, HSCs are associated
with the sinusoidal endothelium (Kiel et al., 2005), but it
remains to be determined whether it represents a functional
niche or only a transition site (Purton and Scadden, 2008). The
use of in vivo and ex vivo time-lapse confocal microscopy has
nicely shown that transplanted HSCs preferentially localize
close to the endosteal bone surface while committed pro-
genitors localize further away (Lo Celso et al., 2009; Xie et al.,
2009). The most potent HSC niches are most likely hypoxic
(Winkler et al., 2010). The well-defined medullar microenvi-
ronment of the nichesmaintainsmost HSCs in an immature and
quiescent/slow-cycling state, the quiescence status being the
hallmark of their long-termHSC properties (Wilson et al., 2008;
Cheshier et al., 1999). A small pool of HSCs will eventually self-
renew only a few times during the lifetime (Wilson et al.,
2008). However, perturbation of homeostasis promotes their
self-renewal more rapidly (Wilson et al., 2008). The mesen-
chymal stem cells (which have adipogenic, osteogenic and
chondrogenic potential), that express the intermediate fila-
ment protein nestin, were recently described as a very
important player in maintaining the function of the HSC niche
(Mendez-Ferrer et al., 2010). Such cells produce SDF-1α
(CXCL12) and SCF (Stem Cell Factor) that are important for
HSC maintenance. These factors are part of a long and non-
exhaustive list of intrinsic and extrinsic factors essential for
HSC fate regulation. It includes transcription factors (e.g. SCL,
Runx1, Cbfβ, Lmo2, GATA2), cell cycle regulators (e.g.
p27kip1, p21cip1/waf1), hematopoietic cytokines (e.g. TPO,
Flt3/Flk2 ligand, IL-3) anddevelopmental regulators (e.g. BMP-
4, Tie2/Angiopoietin-1, Wnt/β-catenin, TGF-β/p21, VCAM-1,
Hedgehog, Notch/Jagged 1) (Zon, 2008). Nevertheless, no
studies have yet pinpointed the exact molecular network
architecture that distinguishes self-renewing from non-self-
renewing hematopoietic cells.
Bone marrow niches, where the pool of HSCs is main-
tained constant in adults, are now well described. This is not
the case for the successive niches where HSCs transit
throughout development. Thus the study of hematopoietic
cells and their various surrounding microenvironments during
ontogeny has become very important in providing some of
the missing pieces of the puzzle which explain how HSCs are
generated and expanded without stem cell potential loss. To
that end, it is first important to understand where they are
generated. We will therefore next review the current
knowledge about the anatomical origin of HSCs.
Intra- or extra-embryonic origin of
hematopoietic stem cells: A long historical
uncertainty
It has been impossible so far to ascertain the precise
anatomical site(s) of HSC emergence in the mouse conceptus.
Indeed, the blood is already circulating (starting at E8.25–8.5)
(Ji et al., 2003) between extra- and intra-embryonic tissues at
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(Fig. 1). Thus, it cannot be ruled out that HSCs emerge in one
site and rapidly colonize another site via the blood circulation.
Lessons can be learned from experiments performed in
the different mammalian and non-mammalian animal models
available. In particular, the avian embryo is a very powerful
model, which has been instructive since the beginning of
research on developmental hematopoiesis. The in ovo
development of avian embryos allows for easy access and
manipulation, such as the injection of cells, the graft of
tissues (prior blood circulation) or the ex vivo development
of embryos cultured in vitro (Stern, 2005). In the late 1960s,
Moore and Owen hypothesized that all HSCs were of YS origin
because the transplantation of 7-day YS cells into 14-day-old
irradiated chicken embryos led to the colonization of
lymphoid organs (Moore and Owen, 1967). The hypothesis
of a YS HSC origin was soon challenged when hetero-specific
chimeras, composed of quail embryos grafted on chick YS,
were generated before the start of circulation between the
embryo and YS (Dieterlen-Lievre, 1975). Quail cells are easily
recognizable from chicken cells by their dark nucleus, as well
as by the use of species-specific antibodies. The analysis of
chimeras revealed that all blood cells were of quail origin,
thus demonstrating their intra-embryonic origin (ruling out
their YS origin). Quail cells were indeed able to colonize the
spleen and thymus rudiments, the bursa of Fabricius and
bone marrow (Dieterlen-Lievre, 1975). The generation of
chick–chick homo-specific chimeras (allowing the growth of
the animal until adulthood) definitively confirmed the intra-
embryonic origin of adult blood (Lassila et al., 1978). In the
amphibian model, grafting strategies are also applicable due
to the external development of the embryo. Blood cells in
the Xenopus (frog) are found in two different compartments:
the ventral blood island (VBI) and the dorsal lateral plate
(DLP, mesodermal region containing the dorsal aorta). VBI is
the mammalian YS equivalent and DLP is the AGM equivalent.
When VBI is grafted in a host Xenopus, it contributes to the
transient production of erythroid cells that last only during
the embryonic stage (Turpen et al., 1981). In contrast, the
graft of DLP leads to the durable production of both lymphoid
and myeloid cells, proving the definitive hematopoietic
potential of the DLP region (Turpen et al., 1981). Interest-
ingly, VBI and DLP compartments derive from distinct
blastomeres as early as the 32-cell embryo stage (Ciau-Uitz
et al., 2000).
The remarkable grafting experiments performed in avian
and amphibian models unambiguously showed the intra-
embryonic origin of adult HSCs in both species. Such grafting
strategies are not feasible so far inmammalian embryos due to
their intra-uterine development. However, some trials have
been made to determine the site of HSC origin. These
experiments use tissues isolated before the onset of circula-
tion to exclude any possible contamination by cells migrating
from one site to another via the blood circulation. Pre-
circulatory E8 YS cells injected into an E8 host YS cavity could
provide (1 month after transplantation) CFU-S progenitors
able to form spleen colonies when the cells were transplanted
into secondary recipients (Weissman et al., 1978; Ueno and
Weissman, 2010). Unfortunately, the intra-embryonic coun-
terpart was not tested in that study. Alternatively, Samokhva-
lov et al. used a genetic labeling approach to mark, by using a
tamoxifen inducible promoter, Runx1 expressing cells during arestricted time period of early embryonic development (E7.5–
E8.5) (Samokhvalov et al., 2007). Runx1 is an essential
transcription factor for the formation of HSCs (Okuda et al.,
1996; Wang et al., 1996; Sasaki et al., 1996), but is also
expressed by early hematopoietic cells located in the YS blood
islands (Samokhvalov et al., 2007). Assuming that tamoxifen
induced labeling is restricted to the aforementioned period of
time, they were able to trace the fate of the YS Runx1
expressing cells and found that all blood lineages were labeled
in adults (9–12 months old), including the phenotypically
definedHSCpopulation (Samokhvalov et al., 2007). Therefore,
both studies argue in favor of a YS origin for at least part of the
adult HSC population. Nevertheless, in another experiment,
cultured pre-circulatory YS and P-Sp (E8) were tested for their
ability to reconstitute adult irradiated immunodeficient mice
(Rag2−/−γc−/− (Colucci et al., 1999)) (Cumano et al., 2001).
Only the P-Sp region could provide long-term multilineage
reconstitution in this type of immunodeficient recipients that
were alymphoid and devoid of NK cell activity. Cultured YS
cells could only provide short-term myeloid reconstitution.
Although this experiment suggests that HSCs could have an
entirely intra-embryonic origin, one could conclude that the ex
vivo YS does not provide the appropriate environment for HSC
precursors to mature into a transplantable cell type.
Thus, it is worth mentioning that none of these
aforementioned studies undoubtedly provide a definitive
answer concerning the potential origin of HSCs in the mouse
embryo. To add to the complexity, it is possible, as shown in
the Xenopus embryo (Turpen et al., 1997) and suggested in
mouse (Matsuoka et al., 2001), that both YS and P-Sp have
intrinsic HSC potential, but that the in vivo microenviron-
ment would define the fate of HSC precursor cells. Despite
uncertainty on the anatomical origin of HSCs, much work has
been performed to understand what cell type developmen-
tally precedes HSCs.Cellular origin of hematopoietic stem cells: The
hemogenic endothelium
The observation of both a temporal and spatial localization of
blood and endothelial cells in the YS blood islands led to the
concept of the hemangioblast, a common precursor for
hematopoietic and endothelial cells (Sabin, 1920). Since
then, there has been genetic and functional evidence for this
concept. For example, Flk-1 deficient embryos lack blood and
endothelium (Shalaby et al., 1995). Likewise, Flk1−/− ESCs fail
to contribute to blood and endothelial lineages in chimeras,
suggesting the existence of Flk1+ hemangioblast cells (Shalaby
et al., 1997). In chickens,mesodermal cells expressing the Flk1
homologue can differentiate clonally either into endothelial or
hematopoietic lineages in the presence or absence of VEGF
(Eichmann et al., 1997). Also, the blast colony-forming cells
(BL-CFC), identified during mouse ESC differentiation, are
able to generate cells of both endothelial and hematopoietic
lineages (Choi et al., 1998). Such bipotential precursors, most
likely corresponding to the hemangioblast, can be detected in
gastrulating mouse embryos (Huber et al., 2004). They arise in
the primitive streak before migrating to the YS, where they
will differentiate in vivo into hematopoietic and endothelial
cells (Huber et al., 2004; Vogeli et al., 2006).
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precursor at the origin of early YS hematopoiesis (Huber,
2010). However, a strikingly close connection between
endothelial and hematopoietic cells can also be observed
later on, in the main intra-embryonic vessels (the dorsal
aorta and the umbilical and vitelline arteries) (Dantschakoff,
1909; Dieterlen-Lievre et al., 2006; Yokomizo and Dzierzak,
2010). There, hematopoietic cells are often seen grouped
together in clusters of cells (Intra-Aortic Hematopoietic
Clusters, IAHCs), tightly attached to the endothelial layer of
the vessels. This close association between endothelium and
hematopoietic cells has led to the hypothesis in the early
20th century that specialized endothelial cells, termed
hemogenic, would have the ability to give rise to hemato-
poietic cells (Dantschakoff, 1909; Jordan, 1917). The
presence of IAHCs has been described in many vertebrate
species (Dieterlen-Lievre et al., 2006). Decades later, it was
also shown by immunostaining on fixed embryo sections that
IAHCs express both hematopoietic and endothelial markers,
again emphasizing the close developmental relationship
between the two cell lineages (Garcia-Porrero et al.,
1998). IAHCs, due to their morphologic and phenotypic
characteristics, are presumed to contain hematopoietic
stem and progenitor cells (Dieterlen-Lievre and Martin,
1981). This is now, in part, confirmed since mice deficient
for the transcription factor Runx1, that do not have any HSCs
or progenitors, are also devoid of IAHCs (embryos die around
E11.5) (Okuda et al., 1996; Wang et al., 1996; Cai et al.,
2000; North et al., 1999). In addition, HSCs and IAHC cells co-
express similar HSC markers (e.g. c-kit) and endothelial
markers (e.g. CD31, VE-cadherin, CD34) at E11.5.
The hypothesizedendothelial origin of IAHCs (and therefore
of the putative HSCs) was first tested in the avian model. Pre-
IAHC stage embryos received injections directly into the heart
with Ac-DiI-LDL (endothelial cells specifically uptake this
molecule) and were examined 24h later. Newly formed IAHCs
were found to express the pan-hematopoietic marker CD45
while still retaining the Ac-DiI-LDL staining (Jaffredo et al.,
1998, 2000). Such experiments therefore proved the endo-
thelial origin of the newly formed hematopoietic cells. Such
specialized endothelial cells capable of generating hemato-
poietic cells are referred to as hemogenic. Similar lineage
tracing experimentswere also performed in themouse embryo
and gave a similar conclusion (Sugiyama et al., 2003). The
transition from endothelial cells to hematopoietic cells is now
well known in the chicken embryo (Fig. 2). The ventral
endothelial cells become thicker, start to express CD45 and
form IAHCs. The endothelial floor is progressively replaced by
endothelial cells of somitic origin that are no longer hemogenic
(Pouget et al., 2006). Such a process regulates the aortic
hematopoietic production both in time and space. In mice, an
alternative hypothesis has been proposed based on the
observation of a cell population located in the sub-aortic
mesenchyme that expresses hematopoietic markers (Bertrand
et al., 2005). According to this hypothesis, HSC precursors
would migrate through the endothelium (without taking any
characteristics of the endothelium) and bud into the lumen of
the aorta to form IAHCs.
Thus, various experimental approaches have been under-
taken to determine the exact cellular origin of HSCs in
different animal models. Constant cell labeling and time-
lapse imaging performed during mouse ESC cultures and BL-CFC development have shown that the hemangioblast
generates hematopoietic cells through the formation of a
hemogenic endothelial intermediate population (Lancrin et
al., 2009; Eilken et al., 2009). Such cells are also present in
gastrulating embryos. Another strategy has been to perform
lineage tracing of endothelial cells in vivo, by marking these
cells at a precise stage of development using Cre-mediated
recombination driven by the VE-Cadherin (mouse) (Zovein et
al., 2008; Oberlin et al., 2010) or KDR promoter (zebrafish)
(Bertrand et al., 2010) (two genes expressed by endothelial
cells). In these conditions, a portion of adult hematopoietic
cells from all hematopoietic lineages were labeled indicating
that their ancestors had undergone an endothelial step at an
earlier stage during mouse and zebrafish development.
Furthermore, conditional deletion of Runx1 in the endothe-
lial compartment completely impaired HSC as well as IAHC
formation (Chen et al., 2009). As a whole, these experiments
give further support to the endothelial origin of adult HSCs.
It is now clear that adult HSCs are generated via an
endothelial step at an earlier stage during embryonic
development. However, the locations of the specialized
hemogenic endothelial cells (which are so far undistinguish-
able from non-hemogenic endothelial cells) as well as insight
into the mechanism leading to hematopoietic cell commit-
ment remain unclear. In order to answer these questions, in
vivo live imaging approaches have been used. Zebrafish
embryos are transparent and are therefore a powerful tool
for live microscopic observation. Three independent groups
used confocal microscopy to look at the aortic region of KDR-
GFP zebrafish embryos during different time points of
embryonic development: 24.5–30 hours post fertilization
(h.p.f.) (Lam et al., 2010), 30–38 h.p.f. (Bertrand et al.,
2010) and 36–52 h.p.f. (Kissa and Herbomel, 2010). In all
cases, the emergence of hematopoietic cells from ventral
endothelial cells of the dorsal aorta was observed. This
hematopoietic commitment coincided with CD41, Lmo2, c-
myb or Runx1 expression (all beingHSCmarkers). The cells bud
in the sub-aortic mesenchyme and later access the circulation
through the neighboring axial vein (it should be noted that
IAHCs do not seem to form in the lumen of the embryonic aorta
of zebrafish). The transition from endothelial cells to
hematopoietic cells does not require cell division but rather
cell shape transformations. Indeed, hemogenic endothelial
cells bend toward the mesenchyme and round up, leading to
detachment from the neighboring endothelial cells (Fig. 2).
Interestingly, the knock-down of Runx1 leads to the death of
the emerging cells (Kissa and Herbomel, 2010). The zebrafish
model therefore clearly shows that hematopoietic stem/
progenitor cells emerge from a polarized hemogenic endothe-
lium located in the ventral part of the dorsal aorta.
Due to the in utero development and opacity of the mouse
embryo, only few attempts have been made thus far to study
the hematopoietic development in the mouse embryo by live
imaging (Jones et al., 2002). Furthermore, the region of
interest, the dorsal aorta, is located deeply within the opaque
embryo. To bypass this problem and access the aorta, thick
slices of non-fixed embryos have been used (Boisset et al.,
2010). Alternatively, dorsal tissues were removed from the
caudal part of the embryo. In both cases, such dissection
procedures allow optical access to the aorta (in the anterior/
posterior axis or from a dorsal perspective). After removal of
the head and tail of the embryos, intra-aortic injection of an
Figure 2 Formation of hematopoietic stem/progenitor cells in the aorta of the chicken and zebrafish embryos. Hematopoietic cells
and intra-aortic hematopoietic clusters (IAHCs) are generated from hemogenic endothelial cells located in the ventral aspect of the
aorta. It is important to note that the process leading to the transition from endothelial cells into hematopoietic cells differs between
avian and amphibian models.
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conjugated to a fluorescent probe was performed. To trace
the putative hemogenic endothelium, Ly-6A (Sca-1)-GFP
transgenic embryos (Ma et al., 2002) were used since Ly-6A is
expressed in some endothelial cells of the aorta as well as in all
HSCs, but not in the surrounding mesenchyme (at E10.5) (de
Bruijn et al., 2002). The hematopoietic commitment was
imaged using CD41-YFP knock-in embryos (Zhang et al., 2007)
since CD41 is so far the earliest marker indicative of
hematopoietic commitment (Ferkowicz et al., 2003; Mikkola
et al., 2003). During time-lapse imaging, it was possible to see
cells from the CD31+ ventral endothelium budding into the
lumen of the aorta (Boisset et al., 2010). These cells either
expressed Ly-6A-GFP or started to express CD41 as they
emerged. They still expressed CD31 after emergence and co-
expressed c-kit (a HSC marker) as shown after staining of the
slices after confocal imaging. Altogether, hematopoietic
stem/progenitor cells emerge from the mouse ventral aortic
endothelium (Boisset et al., 2010; Boisset and Robin, 2010).
However, it is not clear whether the endothelial to hemato-
poietic transition in the mouse embryo requires cell remodel-
ing/bending or asymmetric division. Nevertheless, in the in
vitro ESC model and in vivo in the zebrafish and chicken
embryos, the transition is happening without cell division
(Jaffredo et al., 1998; Eilken et al., 2009; Kissa and Herbomel,
2010). Also, it has been suggested that a hemangioblastic cell
type might be present in the aortic region (He et al., 2010). It
should be noted that a consensus definition for hemogenic
endothelium and hemangioblast is lacking, despite the tworeferring to the close association between blood and endothe-
lium. For instance, the hemangioblast is defined functionally
by its ability to differentiate clonally into both hematopoietic
and endothelial lineages. But it is not clear whether a
hemogenic endothelial cell is also able to do so. If this is
true, a hemogenic endothelial cell would then be a hemangio-
blast with the morphology or phenotype of endothelial cells
(integrated into vessels). If not, then hemogenic endothelial
cells would only give rise to blood cells and not to endothelium.
Thus, more work needs to be carried out in order to clarify this
issue.Remaining questions
The presence of numerous IAHCs in the aorta raises many
questions. (1) Although IAHCs are generally believed to be
HSCs, there is an obvious incongruity between the low
number of HSCs (b2 per aorta at E11.5) (as calculated by
limiting dilution and transplantation into irradiated adult
recipients) (Kumaravelu et al., 2002; Gekas et al., 2005;
Robin et al., 2006) and the number of cells that make up the
IAHCs (between 400 and 600 c-kit+ cells at E11.5) (Yokomizo
and Dzierzak, 2010). Thus, most IAHC cells are not genuine
HSCs. (2) Another discrepancy concerns the temporal delay
between the appearance of IAHCs (>E9.5) and HSCs (>E10.5)
(Muller et al., 1994; Yokomizo and Dzierzak, 2010). (3) HSCs
are restricted to the ventral part of the aorta (Taoudi and
Medvinsky, 2007), whereas IAHCs are present all around the
8 J.-C. Boisset, C. Robinaorta of the mouse embryo (Yokomizo and Dzierzak, 2010). It
is important to note that all other species tested have IAHCs
present strictly in the ventral part of the aorta. In addition,
(4) the total number of HSCs present in the entire embryo
increases from 11 to 152 HSCs in 24 h (from E11.5 to E12.5)
(Gekas et al., 2005). Such an amplification would imply ~4
symmetrical divisions (one division every 6 h), which might
be an improbable situation.
All the inconstancies concerning HSCs and IAHCs have led to
the idea that an intermediate cell state exists between the
hemogenic endothelium and the HSC state. These cells are
referred to as pre-HSCs, HSC precursors or pre-definitive HSCs.
No cells isolated from early embryonic stages (bE10.5) are able
to reconstitute a wild-type adult irradiated recipient, the
classical assay to identify HSCs. The first evidence of pre-HSCs
came from experiments showing that YS cells or circulating
blood cells from E9 mouse embryos could long-term reconsti-
tute different W (c-kit) mutants when injected in utero into
E11–E15 fetuses (Toles et al., 1989). Some of the pregnant
dams even showed long-term chimerism. These cells have not
yet been shown to reconstitute an adult irradiated recipient
and thus, by definition, are not classically defined as HSCs, but
are nevertheless capable of self-renewal: the main character-
istic of HSCs (multilineage reconstitution was unfortunately
not tested in these experiments) (Toles et al., 1989). Itwas also
shown that E9 YSandP-Sp cells can reconstitute (long-termand
multilineage) busulfan treated newborn recipients or uncon-
ditionedW41/W41 neonatal mice (Yoder et al., 1997a, 1997b;
Yoder and Hiatt, 1997; Peeters et al., 2005) (Fig. 1). The donor
cells from the primary transplanted recipient could also
reconstitute secondary recipients when injected into adults
(Yoder and Hiatt, 1997). Thus, cells with HSC characteristics
(pre-HSCs) exist before genuine adult-type HSCs. It has been
suggested that pre-HSCs are unable to engraft an adult
recipient because they lack maturity to niche in the adult
microenvironment (Yoder et al., 1997a). For example, they
might not express the required homing molecules or chemo-
kine/growth factor receptors. In addition, MHC class I
molecules are nearly not expressed by embryonic cells isolated
before E10.5, thus becoming potential targets for the host
adult NK cells (Cumano et al., 2001; Jaffe et al., 1990).
An attempt was made to establish the link between pre-
HSCs and HSCs. Ex vivo culture of dissociated/reaggregated
E11.5 AGM explants have been used as a tool to study the
dynamics of HSC production (Taoudi et al., 2008). After 96 h
of culture, a 150-fold HSC expansion was observed in the
reaggregates. Because HSCs were mainly found in the slow-
cycling population, such cell expansion would be better
explained by maturation of pre-HSCs into HSCs, rather than
cell division of a small pool of HSCs. Pre-HSCs appear to be
restricted to the VE-Cadherin+CD45− subpopulation at E10.5,
which maturate into a VE-Cadherin+CD45+ subpopulation at
E11.5 (Taoudi et al., 2008; Rybtsov et al., 2011). Given that
IAHCs also express these markers at E11.5, it seems plausible
that at least part of the IAHCs contain pre-HSCs. However, it
must be remembered that AGM explants performed at early
E10 do not provide any HSCs capable of adult reconstitution
(Medvinsky and Dzierzak, 1996), although the aorta contains
many IAHCs (Yokomizo and Dzierzak, 2010) and cells capable
of newborn reconstitution during these early stages (Yoder
et al., 1997a; Yoder and Hiatt, 1997). Thus, new approaches
are required in order to determine the intermediate stepsneeded for hemogenic endothelial cells to generate fully
potent HSCs.
An interesting remaining question is whether hemogenic
endothelial cells are already committed to producing blood or
whether any endothelial cell is capable of doing so depending
on the influence of a singular environment. It is of interest to
note that hemogenic endothelial cells found in different
animal models are ventrally polarized. Indeed, transplantable
mouse HSCs reside in the sub-dissected ventral part of the
aorta while both dorsal and ventral parts contain hematopoi-
etic progenitors (Taoudi and Medvinsky, 2007). Although there
is a clear polarized location of HSCs in the aorta, the
mechanisms behind it are unclear, but would give profound
insight into how HSCs are generated. In the avian model, the
embryonic aorta is formed by endothelial cells of mixed
origins. The roof and sides of the aorta are formed by
endothelial precursors originating from somitic mesoderm
(Pardanaud et al., 1996). On the other hand, the floor of the
aorta, capable of hematopoietic production, is formed by
precursors migrating from the splanchnopleural mesoderm
(Pardanaud et al., 1996). Since no clonal experiments were
done, it is difficult to conclude on the precise nature of these
precursors. They could be hemangioblasts (that would form
the mature endothelium and hemogenic endothelium) or
already be committed to hemogenic endothelial cell pre-
cursors (that would only integrate with the ventral aortic
endothelium to generate hematopoietic cells).
Following the establishment of the aortic endothelium, the
importance of environmental cues in the fate of specialized
endothelial cells was highlighted. Quail somatopleural meso-
derm placed in contact with endoderm tissues could thereafter
integrate into the floor of the dorsal aorta (although initially
lacking such potential) and form IAHCs. On the other hand,
splanchnopleural mesoderm treated with ectoderm tissues had
a lower potential to integrate into the floor of the aorta
(Pardanaud and Dieterlen-Lievre, 1999). These experiments
suggest that the different types of mesoderm have cells with
hemogenic endothelial potential, but that only the splanchno-
pleural mesoderm instructs these cells to ultimately become
hemogenic. In themousemodel, the aorta dissected alongwith
ventral endoderm tissue (including the gut) provided a greater
repopulation in irradiated adult recipients when compared to
the aorta dissected alongwith dorsal ectoderm tissue (including
the neural tube) (Peeters et al., 2009). Such results suggest that
polarized factors determine hematopoietic fate. In this case,
the next question is to determine which factors are implicated.
In chicken embryos, growth factors such as VEGF, bFGF or
TGFβ1 led to similar effects on quail somatopleural mesoderm,
as with exposure to endoderm tissues (Pardanaud and Dieter-
len-Lievre, 1999). On the other hand, growth factors like EGF
and TGFα could mimic the effect of contact between
splanchnopleural mesoderm and ectoderm (Pardanaud and
Dieterlen-Lievre, 1999). In mice, the culture of AGM as explant
in presence of hedgehog proteins during 3 days enhances the
hematopoietic activity in the AGM (similarly to the explant
culture of AGM plus gut) (Peeters et al., 2009). However, the
reverse situation was observed when AGM dissected with
endoderm (gut) tissue was incubated with blocking antibody
targeting hedgehogs (similar to the explant culture of AGM plus
dorsal tissue), at least in the early stage of HSC emergence
(E10.5) (Peeters et al., 2009). Likewise, in zebrafish embryos,
hedgehog seems to affect the stage before HSC emergence,
9On the origin of hematopoietic stem cells: Progress and controversywhen the dorsal aorta is forming, which eventually affects
definitive hematopoietic specification (Gering and Patient,
2005;Wilkinson et al., 2009). BoneMorphogenetic Protein (BMP)
4 is another inducer of the hematopoietic fate. Again in
zebrafish, it was shown that BMP4 is required for HSC emer-
gence, while not affecting the arterial specification, suggesting
that BMP4 has a latter effect on HSC specification in comparison
to Hedgehog. In mice, a mild increase in HSC activity was
observed after the addition of BMP4 to AGM explant cultures
whereas the addition of Gremlin, a BMP antagonist, greatly
decreased it. Notably, BMP4 expression was predominant in the
ventral part of the aorta in different cell populations, including
the surrounding mesenchyme and cells of the IAHCs (Durand
et al., 2007). IL-3, a well-known adult hematopoietic interleu-
kin, is also a potent survival and amplification factor of mouse
embryonic HSCs (Robin et al., 2006; Robin and Durand, 2010).
Finally, another essential player for definitive hematopoiesis
formation is Notch. However, it seems to be required mainly
when HSCs emerge from the endothelium, either in zebrafish
(Bertrand et al., 2010; Gering and Patient, 2005; Lee et al.,
2009) ormice (Kumano et al., 2003; Robert-Moreno et al., 2005,
2008). Although it is clear that Hedgehogs, BMP4, IL-3 andNotch
act to induce definitive hematopoietic formation, it remains to
be shown which cell types produce and/or respond to these
signals: mesodermic precursor, hemogenic endothelial cells
and/or IAHC cells. It is of interest to note that although the
hemogenic endothelium localization is strictly polarized inmost
models, this seems less stringent in the mouse embryo since
IAHCs are also present, albeit in fewer number, in the roof of the
dorsal aorta (Yokomizo and Dzierzak, 2010; Taoudi and
Medvinsky, 2007).Conclusion
Since the discovery of IAHCs in the early 20th century and of
HSCs about 50 years later, a tremendous amount of work has
been performed to understand their nature, origin and fate.
The connection between HSCs and IAHCs has been established,
as well as their direct endothelial origin. However, important
long-standing questions are still lacking definitive answers.
The formation of HSCs in the embryo is thus one of the most
striking and thought-provoking models to study. From a stem
cell biology perspective, where hierarchy is the gold standard,
it is puzzling to observe that blood stem cells do not derive
directly from a mesoderm undifferentiated blood precursor,
but from a seemingly differentiated—or mature—endothelial
population. Later, migration of HSCs through multiple niches
results in a paradigm for the regulation of the newly acquired
stem cell fate (i.e. the fragile balance between self-renewal,
differentiation and quiescence). Given the profound interest
in reprogramming differentiated cells to a stem cell state, it
will definitely still be of interest to continue pursuing a greater
understanding of how cells acquire self-renewing capabilities
and regulate them in such a natural set of events, as it happens
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